Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | PRKCA | P17252 | 4/20 | 0.65 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.65 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL16457 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL180497 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL6433273 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL56526 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL629793 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL1173235 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL141667 | 1.00 | LMNA (0.66) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL9160363 | 0.98 | LMNA (0.64) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL12489211 | 0.98 | LMNA (0.63) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| Butane SCHEMBL3900185 | 0.97 | LMNA (0.61) | LMNAALDH1A1PRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118948631-B | Oil-in-water cleansing composition | 深圳市护家科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118948631-A | Oil-in-water cleansing composition | 深圳市护家科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-116370328-A | Skin care composition and external skin preparation | 深圳市护家科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| EP-3280448-B1 | ABIRATERONE ACETATE LIPID FORMULATIONS | CAPSUGEL BELGIUM NV (BE) | 2020-12-30 | — | — | EP | claimed |
| US-20200316093-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | CAPSUGEL BELGIUM NV (BE) | 2020-10-08 | — | — | US | claimed |
| US-10722527-B2 | Abiraterone acetate lipid formulations | CAPSUGEL BELGIUM NV (BE) | 2020-07-28 | — | — | US | claimed |
| US-10220223-B2 | Cosmetic composition with a volumizing effect | L'OREAL (FR) | 2019-03-05 | — | — | US | claimed |
| US-20180125863-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | CAPSUGEL BELGIUM NV (BE) | 2018-05-10 | — | — | US | claimed |
| EP-3280448-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | Capsugel Belgium NV (BE) | 2018-02-14 | — | — | EP | claimed |
| WO-2016162229-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | CAPSUGEL BELGIUM N.V. (BE) | 2016-10-13 | — | — | WO | claimed |
| EP-3010487-A1 | NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION | Contract Pharmaceuticals Limited (CA) | 2016-04-27 | — | — | EP | claimed |
| US-9320693-B2 | Cosmetic composition with a volumizing effect | L'OREAL (FR) | 2016-04-26 | — | — | US | claimed |
| WO-2014201541-A1 | NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION | CONTRACT PHARMACEUTICALS LIMITED (CA) | 2014-12-24 | — | — | WO | claimed |
| EP-1800650-B2 | Cosmetic composition providing a voluminous effect | OREAL (FR) | 2013-08-14 | — | — | EP | claimed |
| EP-1800649-B2 | Cosmetic composition with volumising effect | OREAL (FR) | 2012-10-10 | — | — | EP | claimed |
| WO-2011101239-A2 | COSMETIC OR DERMATOLOGICAL USES OF A POWDER COMPRISING A FILLER, AN ESSENTIAL OIL AND A HYDROXYLATED ESTER OF POLYOL AND OF C4 TO C16 CARBOXYLIC ACID(S) | L'OREAL (FR) | 2011-08-25 | — | — | WO | claimed |
| EP-1800650-B1 | Cosmetic composition providing a voluminous effect | OREAL (FR) | 2010-11-03 | — | — | EP | claimed |
| EP-1800649-B1 | Cosmetic composition with volumising effect | OREAL (FR) | 2008-12-10 | — | — | EP | claimed |
| US-20070196301-A1 | Cosmetic composition with a volumizing effect | L'OREAL (FR) | 2007-08-23 | — | — | US | claimed |
| US-20070141003-A1 | Cosmetic composition with a volumizing effect | L'OREAL (FR) | 2007-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10722527-B2 | Abiraterone acetate lipid formulations | AR, CYP19A1, CYP46A1 | LMNA 3660/4885ALDH1A1 1154/4885PRKCA 1072/4885 |
| US-20200316093-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | AR, CYP19A1, CYP46A1 | LMNA 3660/4885ALDH1A1 1154/4885PRKCA 1072/4885 |
| US-20180125863-A1 | ABIRATERONE ACETATE LIPID FORMULATIONS | AR, CYP19A1, CYP46A1 | LMNA 3660/4885ALDH1A1 1154/4885PRKCA 1072/4885 |
| US-20070196301-A1 | Cosmetic composition with a volumizing effect | LIPA, CUTA, LIPG | LMNA 388/4885ALDH1A1 2486/4885PRKCA 2438/4885 |
| US-20070141003-A1 | Cosmetic composition with a volumizing effect | CUTA, ELOVL1, LIPA | LMNA 483/4885ALDH1A1 2197/4885PRKCA 3394/4885 |
| US-10220223-B2 | Cosmetic composition with a volumizing effect | CUTA, LIPA, LIPG | LMNA 271/4885ALDH1A1 2312/4885PRKCA 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.